Arenicin-1 vs Oxyntomodulin
Head-to-head comparison of Arenicin-1 (Arenicin-1) and Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | Oxyntomodulin |
|---|---|---|
| Category | Marine-Derived | Weight Management |
| Full Name | Arenicin-1 | Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide |
| Molecular Weight | 2079 Da | ~4,200 Da |
| Half-Life | n/a | 12-15 minutes |
| Amino Acids | 21 | 37 |
| Typical Dose | n/a | Research doses vary; commonly 100-300 mcg in small human studies |
| Route | preclinical | Subcutaneous/IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 80 |
| Research Status | Pre-clinical | Clinical |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
Oxyntomodulin Benefits
- ✓reduces appetite
- ✓increases satiety
- ✓supports weight loss
- ✓improves postprandial metabolic signaling
Arenicin-1 Dosing
bacterial infection|biofilm disruption
Oxyntomodulin Dosing
Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring
Arenicin-1 Side Effects
- ⚠Arenicola marina
Oxyntomodulin Side Effects
- ⚠nausea
- ⚠GI discomfort
- ⚠decreased appetite beyond target
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
Oxyntomodulin
Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.